MedPath

Effects on Cellulite Appearance

Not Applicable
Completed
Conditions
Body Fat Disorder
Interventions
Device: The ZELTIQ System
Registration Number
NCT04876118
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

Evaluate the safety and feasibility effecting the appearance of cellulite on the thigh using CoolSculpting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
97
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fat ReductionThe ZELTIQ SystemThe treatments are designed to see if the appearance of cellulite can be reduced on the outer thigh with a new applicator design.
Primary Outcome Measures
NameTimeMethod
Percentage of Photographs Correctly Identified by Blinded Reviewers From the Independent Physician Reviewer PanelWeek 12 post final treatment (up to 24 weeks after first treatment)

Photographs of the treatment area taken at baseline and 12-weeks after final treatment were assessed for visual changes. Reported here is the mean percentage (%) of correct baseline identification of images by the blinded independent reviewers.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Device and/or Procedure Related Adverse Events (AEs) and Device-related Serious Adverse Events (SADEs)Baseline up to 36 weeks post final treatment (up to 42 weeks from first treatment)

An AE was any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in participants, whether or not considered related to treatment. A serious AE was an AE that resulted in death, serious deterioration in health, permanent impairment of a body structure/function, was life-threatening, required hospitalization or medical/surgical intervention, led to fetal distress or death, congenital abnormality, or birth defect. An adverse devise effect (ADE) was any sign, symptom, or disease determined by the Investigator to have a causal relationship or possible causal relationship with the investigational device, including any AE resulting from insufficient or inadequate instructions for use, deployment, implantation, installation, or operation, or any malfunction of the device or from use error or intentional misuse of the device. A SADE was an ADE that resulted in any of the consequences characteristic of a serious AE.

Trial Locations

Locations (6)

Investigate MD

🇺🇸

Scottsdale, Arizona, United States

Rebecca Fitzgerald, MD Dermatology

🇺🇸

Los Angeles, California, United States

Aesthetic Solutions, P.A.

🇺🇸

Chapel Hill, North Carolina, United States

Sasaki Advanced Aesthetics Medical Center

🇺🇸

Pasadena, California, United States

Laser and Skin Surgery Center of Northern California

🇺🇸

Sacramento, California, United States

Innovation Research Center

🇺🇸

Pleasanton, California, United States

© Copyright 2025. All Rights Reserved by MedPath